Shareholder Investigation Announced Against AN2 Therapeutics, Inc.
Purcell & Lefkowitz LLP has announced an investigation into AN2 Therapeutics, Inc. (NASDAQ: ANTX) on behalf of its shareholders. The firm is examining whether the company's directors may have breached their fiduciary duties in connection with recent corporate actions. The law firm invites shareholders to contact them for more information regarding their rights and potential legal options. Purcell & Lefkowitz specializes in representing investors affected by securities fraud or other forms of corporate misconduct, offering free consultations without obligation.
Tickers: $ANTH
Topics: corporate governance fiduciary duties securities fraud